v3.25.4
ACQUISITIONS AND STRATEGIC TRANSACTIONS - Narrative (Details)
1 Months Ended 12 Months Ended
Nov. 13, 2025
USD ($)
Sep. 10, 2025
USD ($)
shares
Jul. 22, 2025
USD ($)
shares
Sep. 30, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Business Combination [Line Items]              
Goodwill     $ 0   $ 177,571,000 $ 329,589,000 $ 334,620,000
Loss on acquisition         6,233,000 0 0
Proceeds from sale of trademark $ 82,500,000       82,500,000 0 0
Gain on sale of trademark $ (5,700,000)       $ (5,679,000) $ 0 $ 0
Novaestiq Corp              
Business Combination [Line Items]              
Asset acquisition, voting equity interest acquired, percentage     100.00%        
Asset acquisition, contingent consideration transferred, equity interest, remaining shares issuable (in shares) | shares     3,273,000        
Asset acquisition, contingent consideration transferred, equity interest, shares issued (in shares) | shares       3,273,000      
Asset acquisition, net revenue, threshold limit minimum       $ 100,000,000      
Asset acquisition, net revenue, threshold limit maximum       $ 200,000,000      
Loss on acquisition     $ 6,200,000        
Royalty sale (in percentage)   0.05          
Royalty expense   $ 120,000,000.0          
Novaestiq Corp | Class A Ordinary Shares              
Business Combination [Line Items]              
Asset acquisition, contingent consideration transferred, equity interest, maximum shares available to be issued | shares     9,819,000        
Shares, issued (in shares) | shares   3,273,000